Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

Press releases published on July 13, 2026

an hour ago

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

Indeterminate GlobeNewswire

an hour ago

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

Indeterminate GlobeNewswire

an hour ago

Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究

Indeterminate GlobeNewswire

an hour ago

Alamar Biosciences 联合多所顶尖研究型大学推出全国性研究计划，推进神经退行性疾病血液生物标志物相关研究

Indeterminate GlobeNewswire

3 hours ago

AI Transforms Biometrics-as-a-Service in Medical Devices, Attracting $178M in Investment Activity

Indeterminate GlobeNewswire

3 hours ago

Good News for Hundreds of Thousands of Permanently Blind People in Vietnam

Indeterminate GlobeNewswire

3 hours ago

Zealand Pharma - Transactions related to share buy-back program (week 28, 2026)

Indeterminate GlobeNewswire

3 hours ago

ENT & Allergy Associates Welcomes Renowned Otolaryngologist and Facial Plastic Surgeon Sydney C. Butts, MD, FACS

Indeterminate GlobeNewswire

4 hours ago

Sienna Senior Living Named One of Canada's Best Companies by TIME and Statista for Second Consecutive Year

Indeterminate GlobeNewswire

4 hours ago

BrewDog Waterloo to Host England's Biggest Pub Watch Party for Blockbuster Semifinal

Indeterminate GlobeNewswire

5 hours ago

Acentra Health Appoints Michael Kingston as Chief Digital & Information Officer to Lead Technology and AI Innovation

Indeterminate GlobeNewswire

5 hours ago

Aegis Treatment Centers Opens New Medication Unit in Yreka, Opening Up Access to Opioid Treatment in Siskiyou County

Indeterminate GlobeNewswire

5 hours ago

Artelo Biosciences Announces Positive Results with ART27.13 in a Nonclinical Model of Paclitaxel-Induced Peripheral Neuropathy

Indeterminate GlobeNewswire

5 hours ago

Bavarian Nordics chikungunyavaccine indsendt til myndighedsgodkendelse i Brasilien

Indeterminate GlobeNewswire

5 hours ago

Bavarian Nordic’s Chikungunya Vaccine Submitted for Regulatory Approval in Brazil

Indeterminate GlobeNewswire

5 hours ago

Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Indeterminate GlobeNewswire

5 hours ago

Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial

Indeterminate GlobeNewswire

5 hours ago

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

Indeterminate GlobeNewswire

5 hours ago

Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

5 hours ago

First patient treated in Phase 2 A-TANGO trial for acute-on-chronic liver failure

Indeterminate GlobeNewswire